InsiderClue
← All stocks

REGENXBIO Inc.

RGNX Net selling
CIK 0001590877 #2797 in the set updated 17 Sep 2026
Bought (120 mo)
$949.38K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$100.66M
$1.08M on a plan · $67.00M straight out of an exercise
Sold at will
$32.57M
135 of 340 sales
Net
−$99.71M
−$31.62M against sales at will

By person

20 insiders · 361 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Mills Kenneth T.
Director
—
$25.72M (109)
−$25.72M
495,925
0.7513%
$4.64M
+255.7%
Vasista Vittal
Chief Financial Officer
—
$19.04M (83)
−$19.04M
246,534
0.3735%
$2.31M
+113.6%
Simpson Curran
Chief Executive Officer
—
$17.42M (30) scheduled
−$17.42M
338,053
0.5121%
$3.16M
—
HAYDEN DONALD J JR
Director
—
$9.34M (19) scheduled
−$9.34M
0
0.0000%
$0.00
−100.0%
Yoo Stephen
Chief Medical Officer
—
$8.72M (31) scheduled
−$8.72M
0
0.0000%
$0.00
—
Christmas Patrick J.
Chief Strategy & Legal Officer
—
$6.41M (34) scheduled
−$6.41M
205,968
0.3120%
$1.93M
—
Fox Allan M.
Director
—
$6.09M (4)
−$6.09M
5,926,520
8.98%
$55.45M
−2.2%
BESHAR LUKE M
Director
—
$4.18M (7) scheduled
−$4.18M
0
0.0000%
$0.00
—
PAKOLA STEVE
Chief Medical Officer
—
$1.73M (9) scheduled
−$1.73M
205,541
0.3114%
$1.92M
—
Danos Olivier
Chief Scientific Officer
—
$1.38M (6) scheduled
−$1.38M
226,348
0.3429%
$2.12M
—
Ciongoli Gregory Austin
Director
$949.38K (2)
—
+$949.38K
118,035
0.1788%
$1.10M
—
KARABELAS ARGERIS N
Director
—
$631.28K (8) scheduled
−$631.28K
28,861
0.0437%
$270.02K
—
Chan Mitchell
Chief Financial Officer
—
—
—
122,815
0.1860%
$1.15M
—
Malzahn Craig
Chief Technology Officer
—
—
—
81,960
0.1242%
$766.82K
+360.0%
Zachary Jennifer
Director
—
—
—
31,871
0.0483%
$298.19K
—
MIGAUSKY GEORGE V
Director
—
—
—
28,861
0.0437%
$270.02K
—
Tasse Daniel
Director
—
—
—
28,861
0.0437%
$270.02K
—
STUMP DAVID C
Director
—
—
—
28,861
0.0437%
$270.02K
—
Glucksmann Alexandra
Director
—
—
—
28,861
0.0437%
$270.02K
—
Bennett Jean
Director
—
—
—
28,861
0.0437%
$270.02K
—

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Mills Kenneth T.
27 Jan 2026
Director
Exercised, kept
225,000
$13.09
$2.95M
Mills Kenneth T.
27 Mar 2025
Director
Exercised, kept
30,752
$3.76
$115.63K
Mills Kenneth T.
8 Aug 2024
Director
Exercised, kept
36,316
$0.85
$30.87K
Vasista Vittal
19 Mar 2024
Chief Financial Officer
Exercised, kept
20,041
$3.76
$75.35K
Vasista Vittal
31 May 2023
Chief Financial Officer
Exercised, kept
35,000
$0.85
$29.75K
Vasista Vittal
20 Jan 2022
Chief Financial Officer
Exercised, kept
29,900
$0.85
$25.42K
Vasista Vittal
27 Jul 2021
Chief Financial Officer
Exercised, kept
10,000
$0.85
$8.50K
Vasista Vittal
31 Mar 2020
Chief Financial Officer
Exercised, kept
10,000
$0.85
$8.50K
Danos Olivier
12 Mar 2019
Chief Scientific Officer
Exercised, kept
5,000
$20.35
$101.75K
Mills Kenneth T.
14 Feb 2019
President and CEO
Exercised, kept
15,000
$0.85
$12.75K
Vasista Vittal
7 Feb 2019
Chief Financial Officer
Exercised, kept
120,000
$0.85
$102.00K
Mills Kenneth T.
1 Feb 2019
President and CEO
Exercised, kept
45,000
$0.85
$38.25K
Danos Olivier
30 Nov 2018
Chief Scientific Officer
Exercised, kept
1,500
$20.35
$30.53K
Showing 250 of 361 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 356
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 197
Sales at will 135
Transactions with no price 0
Shares from compensation/vesting 5,738,322
Sales filed before the plan box existed 134
History held since 12 Dec 2016